Conflict of interest: Nothing to declare.
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma
Article first published online: 4 JAN 2014
© 2014 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 61, Issue 10, pages 1867–1870, October 2014
How to Cite
Rihani, A., Van Maerken, T., De Wilde, B., Zeka, F., Laureys, G., Norga, K., Tonini, G. P., Coco, S., Versteeg, R., Noguera, R., Schulte, J. H., Eggert, A., Stallings, R. L., Speleman, F. and Vandesompele, J. (2014), Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma. Pediatr. Blood Cancer, 61: 1867–1870. doi: 10.1002/pbc.24927
- Issue published online: 19 AUG 2014
- Article first published online: 4 JAN 2014
- Manuscript Accepted: 6 DEC 2013
- Manuscript Received: 26 OCT 2013
- Childhood Cancer Fund
- National Cancer Plan of the Belgian State (Action 29)
Additional Supporting Information may be found in the online version of this article at the publisher's web-site.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.